BioSpace News Archive

-Estimated Market Opportunity of Greater than $100 Million -Alkindi Sprinkle NDA has been Assigned a September 29, 2020 Prescription Drug User Fee Act Date -Alkindi Sprinkle has been Granted Orphan Drug Designation for Adrenal Insufficiency in Pediatric Patients -Eton Executed $7.8 Million Equity Financing and $2.0 Million Amended Credit Facility to Support Alkindi Sprinkle Transaction

TELA Bio, Inc. (“TELA”) today reported financial results for the fourth quarter and full year ended December 31, 2019. Recent Highlights Recognized revenue of $4.9 million for the fourth quarter and $15.4 million for the full year

Arcturus Therapeutics (the “Company”, NASDAQ: ARCT), a leading messenger RNA medicines and vaccines company, today provided details about the Company’s strategy to rapidly learn about the safety and efficacy profile of its COVID-19 vaccine using Duke-NUS’ genetic correlation system. Duke-NUS, the Company’s partner, developed a process to track genetic changes and their correlations that augment testing of vaccines. There are specific gene chang

Seneca Biopharma, Inc. today reported its financial results for the year ended December 31, 2019 . Business Highlights for the Year Ended December 31, 2019 In early 2019, the Company shifted its ope

China’s leading online pharmaceutical network and healthcare service provider is partnering with the Wenjiang People’s Hospital in Chengdu to build an online cancer diagnosis and treatment platform for rare tumors using imported drugs.

Investors Double Down on Non-Video Telehealth to Aid Frontline Healthcare Workers in Treating Patients While Focus Turns to Flattening the Curve, Raising Clinical Capacity

Company Offers Support During Pandemic with Childcare Stipend and Supplemental Pay; Plans to Hire 6,000 Additional Caregivers; Maintains Heightened Safety Measures

In response to the COVID-19 pandemic, Priority Health announced further expanded access to home medication deliveries for all its members with the largest pharmacies in the state.

NanoVibronix, Inc., (NASDAQ: NAOV), today announced that it has reached out to regulatory agencies around the world to inform them of the potential benefits for greater use of the product on compromised patients.

As more and more people across the country continue to look for safe and convenient options to pick up daily essentials amidst the COVID-19 pandemic, Walgreens is now offering select products at its more than 7,300 pharmacy drive-thrus nationwide.